2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis

Detalhes bibliográficos
Autor(a) principal: Pereira, Ivânio Alves
Data de Publicação: 2012
Outros Autores: Mota, Licia Maria Henrique da, Cruz, Boris Afonso, Brenol, Claiton Viegas, Fronza, Lucila Stange Rezende, Bertolo, Manoel Barros, Freitas, Max Victor Carioca de, Silva, Nilzio Antonio da, Louzada Junior, Paulo, Giorgi, Rina Dalva Neubarth, Lima, Rodrigo Aires Corrêa, Pinheiro, Geraldo da Rocha Castelar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/146998
Resumo: Objective: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. Method: Literature review with articles’ selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. Results and conclusions: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a fi rst biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-infl ammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient’s vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated.
id UFRGS-2_2ed98316db1012483b4fcc49deec79af
oai_identifier_str oai:www.lume.ufrgs.br:10183/146998
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Pereira, Ivânio AlvesMota, Licia Maria Henrique daCruz, Boris AfonsoBrenol, Claiton ViegasFronza, Lucila Stange RezendeBertolo, Manoel BarrosFreitas, Max Victor Carioca deSilva, Nilzio Antonio daLouzada Junior, PauloGiorgi, Rina Dalva NeubarthLima, Rodrigo Aires CorrêaPinheiro, Geraldo da Rocha Castelar2016-08-10T02:15:31Z20120482-5004http://hdl.handle.net/10183/146998000986379Objective: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. Method: Literature review with articles’ selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. Results and conclusions: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a fi rst biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-infl ammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient’s vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated.application/pdfengRevista brasileira de reumatologia. Campinas. Vol. 52, n. 2 (mar./abr. 2012), p. 474-495Artrite reumatóideConsensoTerapêuticaRheumatoid arthritisTherapyBrazilAntirheumatic agentsConsensus2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritisConsenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide info:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000986379.pdf000986379.pdfTexto completo (inglês)application/pdf660192http://www.lume.ufrgs.br/bitstream/10183/146998/1/000986379.pdf085c1c6cf20441e8f89238da14a5975bMD51TEXT000986379.pdf.txt000986379.pdf.txtExtracted Texttext/plain119643http://www.lume.ufrgs.br/bitstream/10183/146998/2/000986379.pdf.txt30a419ed7e85c12563fb0a14b8340416MD52THUMBNAIL000986379.pdf.jpg000986379.pdf.jpgGenerated Thumbnailimage/jpeg1654http://www.lume.ufrgs.br/bitstream/10183/146998/3/000986379.pdf.jpg0e08191839a1046490563a23d32f4a24MD5310183/1469982018-10-29 08:26:06.455oai:www.lume.ufrgs.br:10183/146998Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-10-29T11:26:06Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
dc.title.alternative.pt_BR.fl_str_mv Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide
title 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
spellingShingle 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
Pereira, Ivânio Alves
Artrite reumatóide
Consenso
Terapêutica
Rheumatoid arthritis
Therapy
Brazil
Antirheumatic agents
Consensus
title_short 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
title_full 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
title_fullStr 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
title_full_unstemmed 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
title_sort 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis
author Pereira, Ivânio Alves
author_facet Pereira, Ivânio Alves
Mota, Licia Maria Henrique da
Cruz, Boris Afonso
Brenol, Claiton Viegas
Fronza, Lucila Stange Rezende
Bertolo, Manoel Barros
Freitas, Max Victor Carioca de
Silva, Nilzio Antonio da
Louzada Junior, Paulo
Giorgi, Rina Dalva Neubarth
Lima, Rodrigo Aires Corrêa
Pinheiro, Geraldo da Rocha Castelar
author_role author
author2 Mota, Licia Maria Henrique da
Cruz, Boris Afonso
Brenol, Claiton Viegas
Fronza, Lucila Stange Rezende
Bertolo, Manoel Barros
Freitas, Max Victor Carioca de
Silva, Nilzio Antonio da
Louzada Junior, Paulo
Giorgi, Rina Dalva Neubarth
Lima, Rodrigo Aires Corrêa
Pinheiro, Geraldo da Rocha Castelar
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pereira, Ivânio Alves
Mota, Licia Maria Henrique da
Cruz, Boris Afonso
Brenol, Claiton Viegas
Fronza, Lucila Stange Rezende
Bertolo, Manoel Barros
Freitas, Max Victor Carioca de
Silva, Nilzio Antonio da
Louzada Junior, Paulo
Giorgi, Rina Dalva Neubarth
Lima, Rodrigo Aires Corrêa
Pinheiro, Geraldo da Rocha Castelar
dc.subject.por.fl_str_mv Artrite reumatóide
Consenso
Terapêutica
topic Artrite reumatóide
Consenso
Terapêutica
Rheumatoid arthritis
Therapy
Brazil
Antirheumatic agents
Consensus
dc.subject.eng.fl_str_mv Rheumatoid arthritis
Therapy
Brazil
Antirheumatic agents
Consensus
description Objective: To elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. Method: Literature review with articles’ selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. Results and conclusions: 1) The therapeutic decision should be shared with the patient; 2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; 3) treatment should be conducted by a rheumatologist; 4) the initial treatment includes synthetic DMARDs; 5) methotrexate is the drug of choice; 6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; 7) exceptionally, biologic DMARDs can be considered earlier; 8) anti-TNF agents are preferentially recommended as the initial biologic therapy; 9) after therapeutic failure of a fi rst biologic DMARD, other biologics can be used; 10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; 11) oral corticoid is recommended at low doses and for short periods of time; 12) non-steroidal anti-infl ammatory drugs should always be prescribed in association with a DMARD; 13) clinical assessments should be performed on a monthly basis at the beginning of treatment; 14) physical therapy, rehabilitation, and occupational therapy are indicated; 15) surgical treatment is recommended to correct sequelae; 16) alternative therapy does not replace traditional therapy; 17) family planning is recommended; 18) the active search and management of comorbidities are recommended; 19) the patient’s vaccination status should be recorded and updated; 20) endemic-epidemic transmissible diseases should be investigated and treated.
publishDate 2012
dc.date.issued.fl_str_mv 2012
dc.date.accessioned.fl_str_mv 2016-08-10T02:15:31Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/146998
dc.identifier.issn.pt_BR.fl_str_mv 0482-5004
dc.identifier.nrb.pt_BR.fl_str_mv 000986379
identifier_str_mv 0482-5004
000986379
url http://hdl.handle.net/10183/146998
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Revista brasileira de reumatologia. Campinas. Vol. 52, n. 2 (mar./abr. 2012), p. 474-495
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/146998/1/000986379.pdf
http://www.lume.ufrgs.br/bitstream/10183/146998/2/000986379.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/146998/3/000986379.pdf.jpg
bitstream.checksum.fl_str_mv 085c1c6cf20441e8f89238da14a5975b
30a419ed7e85c12563fb0a14b8340416
0e08191839a1046490563a23d32f4a24
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224905901998080